Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-3207 dose-finding study in acute migraine
NCT00712725Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of MK-3207 in migraine, sponsored by Merck & Co.. Started Jul 2008; status: completed.
02
Drugs
MK-3207
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00712725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00712725.